Cutting edge research deserves high-tech solutions
Reno-NL
Reno-NL, a spin-off from the University Medical Center Groningen (The Netherlands), was founded in 2025 and built on long-standing experience with organ machine perfusion and preservation technology research.
Our highly skilled and motivated team, composed of experts from various disciplines, played a pioneering role in advancing this groundbreaking technology.
We are specialized in extracorporeal kidney perfusion and associated downstream analysis to advance medical innovations with high translational accuracy. By providing our experimental procedures not only for transplantation, but also for drug testing and medical device research, we aim to innovate and support pharmaceutical and health-tech companies in developing next-generation solutions.
Our tailored approach ensures high-quality, clinically relevant results, making the transition to patient applications more predictable, cost-effective, and impactful.
Fields of interest
Transplantation
Pharmacology
Medical device
Prof. Dr. Henri Leuvenink: Main founder
"We are a team of professionals specializing in organ perfusion, committed to advancing medical research and technology. With our expertise and dedication, we work to improve the preservation and viability of organs for transplantation."
Why choose for Reno-NL?
At Reno-NL, we offer contract research services and believe in a collaborative approach to ensure the best outcomes. Our workflow is based on co-creation with our clients from question to product ensuring that the process is tailored to meet your specific needs. We thereby focus on providing the highest level of service and delivery of high-quality, reliable results. We start by understanding your objectives, challenges, and requirements. Together, we design the most optimal strategy that aligns with your goals, utilizing our cutting-edge research models and expertise. Also throughout the process, our team will work closely with you and discuss adjustments as needed to ensure the best outcome possible. By combining your ideas with our scientific expertise, we turn complex questions into actionable, innovative solutions.
Human-relevant models that save time and money
Our approach delivers significant financial advantages. By eliminating less predictive in vitro models and costly in vivo animal experiments, our clients can reduce overall research expenses. Additionally, testing therapies on human-relevant models enhances predictive accuracy, which lowers the risk of costly failures during later clinical trial phases, ultimately improving the cost-effectiveness of your research and development efforts.
Some of our existing collaborators
